Literature DB >> 2812351

Chronic cerebrovascular insufficiency on the xenon CT scan.

K Holl1, N Nemati, H Heissler, M Gaab, B Haubitz, H Becker, H Dietz.   

Abstract

Several investigators have described CT-negative low flow areas in TIA and stroke patients in the chronic phase. The emission tomographic SPECT image they employed has, in contrast to the xenon CT method, no direct relation to the x-ray transmission CT scan. The aim of our study was to study the phenomenon of CT-negative low flow areas using the xenon CT method, a method especially well suited for such cases. 57 xenon CT examinations were performed in 40 TIA patients. Flow data from brain tissue which appeared to be anatomically intact in a slice 5 cm above the canthomeatal plane were analyzed. In the TIA group, the flow in the gray matter was found to be significantly lower on the clinically affected side: symptomatic side, 61.8 +/- 14.7 ml/100 g/min; asymptomatic side, 66.4 +/- 15.8 ml/100 g/min (p less than 0.001). In the stroke group, the flow in the white matter was also affected; symptomatic side, 31.2 +/- 9.8 ml/100, g/min; asymptomatic side, 35.3 +/- 11.1 ml/100 g/min (p less than 0.01). Gray matter: symptomatic side, 56.1 +/- 11.4 ml/100 g/min; asymptomatic side, 66.0 +/- 11.0 ml/100 g/min (p less than 0.001). The findings indicate that the appearance of CT-negative low flow areas in TIA and stroke patients during the chronic phase is the rule rather than the exception. Flow adaptation to anatomic changes not discernible by CT can be differentiated from clinically relevant flow impairment only by testing the cerebrovascular reserve.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2812351     DOI: 10.1007/bf01743986

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  9 in total

1.  Stable xenon enhanced computed tomography in the study of clinical and pathologic correlates of focal ischemia in baboons.

Authors:  H Yonas; D Gur; D Claassen; S K Wolfson; J Moossy
Journal:  Stroke       Date:  1988-02       Impact factor: 7.914

2.  [The cerebral circulation in xenon-CT].

Authors:  A Majewski; K Holl; M Nemati; M R Gaab; H Dietz; H Becker
Journal:  Rontgenpraxis       Date:  1988-09

3.  [Experience with the inhalation of a 33% xenon-(stable-)oxygen mixture in relation to a new method of measuring local cerebral circulation].

Authors:  E Kohmura; P Gürtner; K Holl; N Nemati; G Stoppe; K D Lerch; M Samii
Journal:  Rofo       Date:  1986-05

4.  Regional cerebral blood flow in stroke by 133Xenon inhalation and emission tomography.

Authors:  N A Lassen; L Henriksen; O Paulson
Journal:  Stroke       Date:  1981 May-Jun       Impact factor: 7.914

5.  Flow and neuronal density in tissue surrounding chronic infarction.

Authors:  G Mies; L M Auer; G Ebhardt; H Traupe; W D Heiss
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

6.  Experimental xenon enhancement with CT imaging: cerebral applications.

Authors:  B P Drayer; D Gur; S K Wolfson; E E Cook
Journal:  AJR Am J Roentgenol       Date:  1980-01       Impact factor: 3.959

7.  Regional cerebral blood flow in patients with transient ischemic attacks studied by Xenon-133 inhalation and emission tomography.

Authors:  S Vorstrup; R Hemmingsen; L Henriksen; H Lindewald; H C Engell; N A Lassen
Journal:  Stroke       Date:  1983 Nov-Dec       Impact factor: 7.914

8.  Cerebral blood flow in acute and chronic ischemic stroke using xenon-133 inhalation tomography.

Authors:  S Vorstrup; O B Paulson; N A Lassen
Journal:  Acta Neurol Scand       Date:  1986-12       Impact factor: 3.209

9.  Cell density and cortex thickness in the border zone surrounding old infarcts in the human brain.

Authors:  M Nedergaard; J Astrup; L Klinken
Journal:  Stroke       Date:  1984 Nov-Dec       Impact factor: 7.914

  9 in total
  1 in total

1.  Reversibility of cerebral ischaemia. Dynamic and xenon computed tomography study on ischaemic cerebrovascular disease.

Authors:  H Ujiie; A Oikawa; K Satoh; H Onda; M Kagawa; K Takakura; Y Kakinoki; Y Ono; N Kobayashi
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.